New injection aims to lower heart risk from fatty substance in blood
Disease control
Not yet recruiting
This early-stage study tests a single injection of BSA204 in 40 Chinese adults with borderline high levels of lipoprotein(a), a fatty substance linked to heart disease. The main goal is to see if the drug is safe and tolerable. Researchers will also check how it affects cholester…
Phase: PHASE1 • Sponsor: Bisirna Therapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated May 04, 2026 05:34 UTC